Slide 1: Cogstate 2012 Annual General Meeting
For personal use only ASSESS • MONITOR • IMPROVE C OG STAT E • C ONF IDE NTIAL • 2 012 A NNUA L G E NE R A L M E E TING • O C T 1 6 , 2 0 1 2
Slide 2: FY2012 Results: A Record Financial Result
FY2012 RESULTS For personal use only A RECORD FINANCIAL RESULT REVENUE UP 48% TO $12M NPAT $2.5M COGSTATE SALES REVENUE AND PROFITABILITY, BY FINANCIAL YEAR 13000 12000 11000 10000 9000 8000 7000 6000 $ MILLIONS 5000 4000 3000 2000 1000 0 (1000) (2000) (3000) Sales Revenue FY 2004 FY 2005 FY 2006 FY
Slide 3: CT Growth: Clinical Trial Sales Contracts
CT GROWTH For personal use only COGSTATE CLINICAL TRIAL SALES CONTRACTS 15 14 13 12 11 10 US $ MILLIONS 09 08 07 06 05 04 03 02 01 FY 2005 FY 2006 FY 2007 FY 2008 FY 2009 FY 2010 FY 2011 FY 2012 INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 4: Clinical Trials Customers
CLINICAL TRIALS CUSTOMERS For personal use only INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 5: Key Staff Additions
KEY STAFF ADDITIONS For personal use only Dr Judy Jaeger VP Clinical Trials Professor of Psychiatry and Behavioural Science at Albert Einstein College of Medicine in NY Adjunct Professor in the CUNY Doctoral program in Neuropsychology Over 25 years experience in clinical and experimental neuropsycho
Slide 6: Axon Sports: Protect & Train the Athletic Brain
For personal use only AXON SPORTS PROTECT & TRAIN THE ATHLETIC BRAIN • Concussion baseline testing (CCAT) • Cognitive Training INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 7: CCAT Existing Users
For personal use only CCAT EXISTING USERS INCLUDE: 2 • AFL • NRL 2 • Australian Racing Board • UK Rugby League & Union • NBA • Toyota (in community level Australian rules football) INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 8: Training Commercialisation Plan
For personal use only TRAINING COMMERCIALISATION PLAN Key installations in elite programs: HE NEC K • Athletes' Performance Institute VE T IN ABO TRA • University of Oregon Football 01 • Brigham Young Football • Cal State Fullerton Baseball • Easton Bell (Baseball) INVESTOR PRESENTATION • OCTOBER 20
Slide 9: Screening: Alzheimer's Disease Opportunity
For personal use only SCREENING THE ABILITY OF COGSTATE TECHNOLOGY TO DETECT THE EARLIEST SIGNS OF COGNITIVE IMPAIRMENT ASSOCIATED WITH ALZHEIMER’S DISEASE REPRESENTS, BY FAR, OUR LARGEST COMMERCIAL OPPORTUNITY INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 10: Merck Partnership
For personal use only MERCK PARTNERED WITH MERCK IN CANADA TO LAUNCH COGNIGRAM IN THE COMING WEEKS ALLOWS DOCTORS TO UTILISE THE TECHNOLOGY WITHIN EXISTING PRACTICE MANAGEMENT ROUTINE CANADA IS A TEST MARKET, LOOK TO EXPAND INTO OTHER TERRITORIES IN TIME INVESTOR PRESENTATION • OCTOBER 2012 ASSESS •
Slide 11: Vision
For personal use only VISION COGSTATE’S PRODUCTS WILL BECOME THE GLOBAL STANDARD FOR ASSESSING MONITORING AND IMPROVING COGNITION INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 12: Cogstate Is Now Poised to Fulfill Its Original Vision
COGSTATE IS NOW For personal use only POISED TO FULFILL ITS ORIGINAL VISION THE NEW COGSTATE HAS EVOLVED BEYOND CLINICAL TRIALS INTO A MULTIFACETED COGNITIVE ASSESSMENT AND TRAINING COMPANY C L I N I C A L T R I A L S ASSESS • MONITOR • IMPROVE INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR •
Slide 13: Supporting This Transformation
For personal use only SUPPORTING THIS TRANSFORMATION TO ENSURE A SUCCESSFUL TRANSFORMATION, WE HAVE BEEN WORKING TO ENSURE THAT COGSTATE’S IDENTITY, RESOURCES AND STRUCTURE ARE ALIGNED TO TAKE ADVANTAGE OF THESE SIGNIFICANT NEW OPPORTUNITIES INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IM
Slide 14: Branding, Organization and Resources
BRANDING, ORGANIZATION AND RESOURCES For personal use only KEY HIRES: ASSESS • MONITOR • IMPROVE C L I N I C A L T R I A L S PRESIDENT-SOPHIE EGHOLM PRESIDENT-JASON SADA PRESIDENT-BRAD O’CONNOR DR JUDY JAEGER JOE GERMAINE MERCK SALES TEAM DR AMY VEROFF DR JASON CROMER DR LISLE KINGERY INVESTOR PRESE
Slide 15: For personal use only
For personal use only INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 16: 2012 Summary
2012 SUMMARY For personal use only GROWTH IN CLINICAL TRIALS PRODUCED OUR MOST PROFITABLE YEAR ACQUISITION OF REMAINING 50% OF AXON SPORTS SIGNIFICANT SCIENTIFIC ADVANCEMENT VIA AIBL AND OTHER STUDIES MERCK CONTRACT INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 17: 2013 Financial Outlook
2013 For personal use only FINANCIAL OUTLOOK CLINICAL TRIALS WILL CONTINUE TO BE THE GENERATOR OF SHORT TERM FINANCIAL PERFORMANCE, THEREBY FUNDING GROWTH IN OTHER AREAS INVESTOR PRESENTATION • OCTOBER 2012 ASSESS • MONITOR • IMPROVE
Slide 18: Cogstate CT Financial Outlook FY 2013
C L I N I C A L T R I A L S COGSTATE CT For personal use only FINANCIAL OUTLOOK FY 2013 US$6.4m of sales contracts since 1 July 2012 (up 56% compared to the same period last year) A$8.5m of revenue secured by contract for the FY13 year (up 33% on the same period last year) Improved sales contracts e
Slide 19: FY2013 Key Milestones
FY2013 For personal use only KEY MILESTONES CLINICAL TRIALS PROFITABILITY AXON SPORTS LAUNCH OF CONSUMER PRODUCTS AXON SPORTS CORPORATE PARTNERSHIPS INITIAL COMMERCIALISATION DATA FOR COGNIGRAM IN CANADA CONTINUED ADVANCEMENTS IN SCIENCE IN AD AND INCREASED USE OF COGSTATE BY SCIENCE LEADERS INVESTO
Slide 20: For personal use only
For personal use only ASSESS • MONITOR • IMPROVE